Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

Tracking the Waivers: Implications of the Wind Down of the COVID-19 Public Health Emergency

By Michael Paddock & Amy Dilcher on March 14, 2023
Email this postTweet this postLike this postShare this post on LinkedIn
GovCon-Blog-Image_Capital-660x283

According to the White House, the end of the COVID-19 national emergency and public health emergency (PHE) declarations is now barely two months away, as they are scheduled to end on May 11, 2023. These declarations provided the federal government with flexibility to waive or modify certain regulatory requirements applicable to the healthcare industry. Once the declarations end, so will the vast majority of these flexibilities and waivers. Accordingly, a relatively short and closing window remains for the healthcare industry – including but not limited to health plans, hospitals, home health agencies, clinics, and entities that offer telehealth services – to prepare their operational, administrative, and clinical teams for the reinstatement of previously waived requirements.

In the attached publication, we identify and summarize some of the most important waivers and flexibilities, as well as the associated payment, administrative, operational, and clinical workflow changes that are implicated by the end of the PHE. 

If you have any questions about the approaching expiration of the PHE and its impact on the regulatory requirements applicable to you or your organization, please contact a member of the Sheppard Mullin Healthcare Team.

Photo of Michael Paddock Michael Paddock

Michael Paddock is a partner in the Governmental Practice in the firm’s Washington, D.C. office.

Read more about Michael PaddockEmail
Photo of Amy Dilcher Amy Dilcher

Amy Dilcher is special counsel in the Corporate Practice Group in the firm’s Washington D.C. office.

Read more about Amy DilcherEmail
  • Posted in:
    Administrative and Regulatory, Health Care and Life Sciences
  • Blog:
    Healthcare Law Blog
  • Organization:
    Sheppard, Mullin, Richter & Hampton LLP
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo